Clinical trial
A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza
NCT01227421 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo Controlled Study of Nitazoxanide in Adults and Adolescents With Acute Uncomplicated Influenza
- Lead sponsor
- Romark Laboratories L.C.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- May 31, 2011
- Enrollment
- 624 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza